Sale!

NKX2-1 Gene Chorea Hereditary Benign Genetic Test

Original price was: $700.Current price is: $500.

-29%

The NKX2-1 Gene Chorea Hereditary Benign NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the NKX2-1 gene associated with benign hereditary chorea. This comprehensive test utilizes next-generation sequencing technology to provide accurate detection of genetic variations that cause involuntary movement disorders. Individuals experiencing unexplained choreiform movements, those with family history of movement disorders, or patients with neurological symptoms should consider this test. The test offers crucial insights for diagnosis, treatment planning, and genetic counseling. Results typically take 3-4 weeks and require blood or DNA samples. This essential genetic screening is available for $500 USD, providing valuable information for managing neurological conditions and making informed healthcare decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

NKX2-1 Gene Chorea Hereditary Benign NGS Genetic DNA Test

Comprehensive Genetic Testing for Benign Hereditary Chorea

The NKX2-1 Gene Chorea Hereditary Benign NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with benign hereditary chorea. This advanced testing methodology provides crucial insights for patients and healthcare providers dealing with movement disorders of genetic origin.

What is NKX2-1 Gene Chorea Hereditary Benign?

Benign hereditary chorea is a rare neurological disorder characterized by involuntary, irregular movements that typically begin in childhood. The condition is caused by mutations in the NKX2-1 gene, which plays a vital role in brain development and thyroid function. Our comprehensive NGS genetic test specifically targets this gene to identify pathogenic variants that may be responsible for movement disorder symptoms.

What Does This Test Measure and Detect?

This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to examine the complete coding region of the NKX2-1 gene. The test detects:

  • Point mutations and small insertions/deletions in the NKX2-1 gene
  • Genetic variants associated with benign hereditary chorea
  • Mutations that may affect thyroid and lung development
  • Inheritance patterns for family planning purposes
  • Specific genetic markers that guide treatment decisions

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is particularly recommended for individuals experiencing:

  • Unexplained choreiform movements beginning in childhood
  • Family history of movement disorders or benign hereditary chorea
  • Involuntary, dance-like movements affecting daily activities
  • Neurological symptoms accompanied by thyroid abnormalities
  • Respiratory issues in conjunction with movement disorders
  • Children with developmental delays and abnormal movements
  • Patients with suspected genetic movement disorders

Key Benefits of NKX2-1 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out benign hereditary chorea with high precision
  • Treatment Guidance: Helps neurologists develop targeted treatment strategies
  • Family Planning: Provides essential information for genetic counseling and family decisions
  • Early Intervention: Enables timely management of symptoms and complications
  • Peace of Mind: Reduces uncertainty about neurological symptoms
  • Comprehensive Care: Facilitates coordinated care between neurologists and genetic specialists

Understanding Your Test Results

Interpreting Genetic Findings

Your test results will provide clear, actionable information:

  • Positive Result: Indicates the presence of a pathogenic NKX2-1 mutation, confirming benign hereditary chorea diagnosis
  • Negative Result: Suggests that NKX2-1 mutations are not the cause of symptoms, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes requiring additional clinical correlation
  • Carrier Status: Determines inheritance patterns for family members

All results include comprehensive interpretation by our genetic specialists and recommendations for next steps in management and family counseling.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700

Additional Test Information

  • Turnaround Time: 3 to 4 weeks
  • Sample Type: Blood, Extracted DNA, or One drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Focus: Neurological Disorders

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session prior to testing
  • Development of detailed family pedigree chart
  • Consultation with a neurologist specializing in movement disorders

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network ensures accessible genetic testing services nationwide.

Take Control of Your Neurological Health

Don’t let uncertainty about movement disorders affect your quality of life. The NKX2-1 Gene Chorea Hereditary Benign NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. Our team of genetic specialists and neurologists are ready to support you through every step of the testing process.

Ready to schedule your genetic test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your neurological health with confidence and precision.